Egalet Ltd. (Westminster, UK) is a specialty pharmaceutical company focusing on developing safe, effective, and tamper-resistant medications to address the growing issue of pain medication abuse. The company uses its proprietary technology to produce novel therapeutics – both on its own and with partners. Egalet’s pipeline of tamper-resistant opioids are in late clinical development.

Egalet was listed on NASDAQ in New York in February 2014 (NASDAQ:EGLT).
Peter Benson, MSc

Chairman & General Partner

Mobile: +45 40 80 48 69